InsuraGuest Technologies Stock (OTC: ISGIF)

Latest News for InsuraGuest Technologies Stock (OTC:ISGIF)

InsuraGuest Technologies Inc is an insurtech (insurance + technology) company disrupting the insurance landscape by utilizing its proprietary software platform to deliver digital insurance to multiple sectors. Its products include InsuraGuest Hospitality and InsuraGuest Technologies' Insurtech Platform. It is a SaaS company utilizing proprietary insurance and technology software to integrate with hotel and vacation rental property management systems to deliver digital insurance products.

News

Penny Stocks

Exclusives

Insurance

General

ISGIF

InsuraGuest Technologies Inc (OTC: ISGIF) has launched a monthly subscription-based insurance product for the Vacation Rental/Short Term Rentals (STR) Insurance marketplace.

EXCLUSIVE: InsuraGuest Unveils Subscription Based Vacation Rental Insurance

INSURAGUEST TECH INC by INSURAGUEST TECHNOLOGIES INC.

InsuraGuest Technologies Inc

TD Cowen analyst Paul Gallant maintains T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) with a Buy and lowers the price target from $204 to $202.

Price Target

Analyst Ratings

TMUS

TD Cowen Maintains Buy on T-Mobile US, Lowers Price Target to $202

Oppenheimer analyst Noah Kaye maintains Waste Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) with a Outperform and raises the price target from $221 to $228.

Oppenheimer Maintains Outperform on Waste Management, Raises Price Target to $228

WIIM

XPEV

XPeng shares are trading higher amid overall strength in Chinese stocks.

TD Cowen analyst John Blackledge maintains Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) with a Hold and raises the price target from $11 to $14.

SNAP

TD Cowen Maintains Hold on Snap, Raises Price Target to $14

TBBB

Tiendas 3B shares are trading higher following Q4 financial results.

Oppenheimer analyst Tyler Batory maintains Tri Pointe Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPH#NYSE">TPH</a>) with a Outperform and raises the price target from $41 to $46.

Oppenheimer Maintains Outperform on Tri Pointe Homes, Raises Price Target to $46

IBRX

ImmunityBio shares are trading higher after the company on Thursday announced overall survival results in its QUILT 3.055 study.

Shares of Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) fell sharply during Friday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/AON/earnings">quarterly financial results</a>.
Aon posted adjusted earnings of $5.66 per share, missing market estimates of $5.91 per share. The company's sales came in at $4.070 billion versus expectations of $4.126 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Aon shares dipped 7.4% to $283.19 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Biodexa Pharmaceuticals Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) shares jumped 73.3% to $1.2475 after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) gained 63% to $0.0845.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares gained 55% to $2.01 after dipping 16% on Thursday.</li>
<li>Universal Logistics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULH#NASDAQ">ULH</a>) surged 45.2% to $47.76 after the company reported better-than-expected first-quarter financial results.</li>
<li>Focus Universal Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) jumped 40% to $0.3967 after the company announced board approval for the spin-off of Lusher.</li>
<li>BranchOut Food Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOF#NASDAQ">BOF</a>) gained 37% to $2.68.</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) gained 29% to $0.6502. Concord Medical filed 2023 annual report on Form 20-F.</li>
<li>Exponent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPO#NASDAQ">EXPO</a>) shares climbed 28.5% to $102.41 after the company reported better-than-expected first-quarter financial results.</li>
<li>Skillsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKIL#NYSE">SKIL</a>) climbed 26.4% to $8.60.</li>
<li>MultiMetaVerse Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMV#NASDAQ">MMV</a>) gained 24.2% to $0.61.</li>
<li>Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) gained 23% to $14.02 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company reported a year-over-year increase in quarterly daily active users.</li>
<li>Tutor Perini Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPC#NYSE">TPC</a>) surged 22.2% to $16.98 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance.</li>
<li>Sunshine Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) surged 22.2% to $0.9888.</li>
<li>U.S. Silica Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLCA#NYSE">SLCA</a>) gained 20% to $15.67 after the company reported first-quarter financial results and entered into a definitive agreement to be acquired by funds managed by affiliates of Apollo.</li>
<li>Earlyworks Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELWS#NASDAQ">ELWS</a>) rose 19.7% to $0.8725 after gaining 19% on Thursday.</li>
<li>Cullinan Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) surged 19.5% to $23.03.</li>
<li>Tevogen Bio Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) shares gained 19.3% to $1.0150 after falling over 43% on Thursday.</li>
<li>ATRenew Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NASDAQ">RERE</a>) surged 18.9% to $1.9150. ATRenew announced appointment of new director.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) gained 17.5% to $13.39.</li>
<li>Freight Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) climbed 17% to $1.0702 after gaining 5% on Thursday.</li>
<li>Skechers U.S.A., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) shares gained 16% to $68.20 after the company reported better-than-expected first-quarter FY24 earnings.</li>
<li>AppFolio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPF#NASDAQ">APPF</a>) surged 16% to $251.22 after the company reported better-than-expected first-quarter financial results and raised its FY24 revenue guidance above estimates.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) gained 15% to $7.97 after the company reported better than expected first-quarter earnings and issued guidance.</li>
<li>ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) shares rose 13.7% to $208.63 after the company reported better-than-expected third-quarter financial results.</li>
<li>Rogers Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) surged 12.7% to $123.46 after the company beat first-quarter EPS and sales estimates.</li>
<li>iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) gained 11.3% to $7.92</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) rose 10.6% to $172.52 the company posted upbeat results for its first quarter. Alphabet's board authorized an additional share repurchase program of up to $70 billion and also announced its first-ever quarterly dividend.</li>
<li>Kratos Defense &amp; Security Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) gained 8.8% to $18.80 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $20 to $27.</li>
<li>AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) climbed 8.6% to $174.20 following second-quarter results.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) shares gained 8.4% to $0.8725 after gaining 15% on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>iClick Interactive Asia Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) shares fell 48.8% to $1.31 after the company announced the termination of its merger agreement.</li>
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) fell 46.7% to $0.1540 after the company reported pricing of $2.7 million public offering.</li>
<li>Safe &amp; Green Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) fell 27.7% to $0.1584.</li>
<li>E-Home Household Service Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) dipped 25.3% to $0.5752.</li>
<li>Nature Wood Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWGL#NASDAQ">NWGL</a>) fell 24.5% to $12.71.</li>
<li>IMAC Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BACK#NASDAQ">BACK</a>) dipped 22.9% to $3.93.</li>
<li>reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) fell 20.8% to $1.10.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) fell 19.3% to $4.84.</li>
<li>Saia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) dipped 19.1% to $439.40 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Kinsale Capital Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>) fell 17.3% to $374.29 following first-quarter results.</li>
<li>Aclarion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) fell 15.5% to $0.3319. Aclarion shares jumped 36% on Thursday after the company announced that its Nociscan solution will be used in the upcoming LIFEHAB trial evaluating the diagnosis and treatment of chronic low back pain.</li>
<li>Oil States International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OIS#NYSE">OIS</a>) fell 15% to $4.5250 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Boyd Gaming Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) shares declined 14.8% to $53.55 after the company reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXI#NASDAQ">ATXI</a>) fell 13.5% to $7.59.</li>
<li>Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSSE#NASDAQ">CSSE</a>) fell 12.7% to $0.2260 after dipping 39% on Thursday. Chicken Soup For The Soul Entertainment received delinquency letter from the Nasdaq.</li>
<li>TriNet Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNET#NYSE">TNET</a>) fell 11.5% to $112.11 after the company reported worse-than-expected first-quarter results and issued weak guidance.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares fell 11.1% to $31.23 after the company reported worse-than-expected first-quarter sales results and issued EPS guidance below estimates.</li>
<li>Accolade, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) dipped 10.6% to $8.22 following quarterly results.</li>
<li>XPO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) fell 10.2% to $106.14.</li>
<li>Atlassian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) shares fell 9.4% to $179.76 after the company reported third-quarter financial results. Atlassian said Scott Farquhar has decided to step down from his role as co-CEO, effective Aug. 31. Cannon-Brookes will continue to lead Atlassian as CEO.</li>
<li>Vincerx Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) shares fell 8.8% to $0.8180 after the company announced pricing of underwritten public offering of common stock and warrants.</li>
<li>SCWorx Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) fell 8.7% to $2.52 after surging 36% on Thursday.   </li>
<li>ACM Research, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACMR#NASDAQ">ACMR</a>) fell 8.3% to $25.94 after announcing preliminary unaudited revenue and shipments for the first quarter.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) shares fell 8.2% to $57.63 after the company reported first-quarter financial results.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) fell 7.8% to $2.52. Processa Pharmaceuticals shares jumped 50% on Thursday after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and announced an $8 price target.</li>
<li>Red Rock Resorts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>) dipped 7.4% to $54.83.</li>
<li>ArcBest Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) declined 7.3% to $128.07.</li>
<li>Allison Transmission Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) fell 6.6% to $74.97 following first-quarter results.</li>
<li>Old Dominion Freight Line, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) fell 6.2% to $184.41.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares declined 6.3% to $129.17 after the company reported first-quarter financial results.</li>
<li>Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) fell 4% to $116.44 following weak earnings.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38459594/how-to-earn-500-a-month-from-dominos-pizza-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Domino&#8217;s Pizza Stock Ahead Of Q1 Earnings</a>

Intraday Update

Markets

Movers

ACCD

ACMR

ACON

AILE

AIRE

ALSN

APPF

ARCB

ATXI

BACK

BDRX

CGEM

CSSE

DXCM

ELWS

EXPO

FCUV

FRGT

GOOG

GOOGL

ICLK

INTC

KNSL

KTOS

Kintara Therapeutics, Inc. - Common Stock

KTRA

Eaton Vance Massachusetts Municipal Income Trust

NIVF

NUWE

NWGL

ODFL

PCSA

PEGY

RERE

ROKU

SAIA

SBFM

SGBX

SKIL

SLCA

TEAM

TNET

TVGN

VINC

WORX

ZVSA

Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) with a Outperform and lowers the price target from $26 to $21.

TDOC

Oppenheimer Maintains Outperform on Teladoc Health, Lowers Price Target to $21

TD Cowen analyst Derrick Wood maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Hold and lowers the price target from $220 to $210.

TD Cowen Maintains Hold on Atlassian, Lowers Price Target to $210

Oppenheimer analyst Owen Lau maintains S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) with a Outperform and raises the price target from $480 to $482.

SPGI

Oppenheimer Maintains Outperform on S&P Global, Raises Price Target to $482

Oppenheimer analyst Suraj Kalia maintains ResMed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) with a Outperform and lowers the price target from $205 to $200.

Oppenheimer Maintains Outperform on ResMed, Lowers Price Target to $200

Oppenheimer analyst Bryan Blair maintains Dover (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) with a Outperform and raises the price target from $187 to $197.

Oppenheimer Maintains Outperform on Dover, Raises Price Target to $197

PLTR

Palantir shares are trading higher as tech and AI stocks gain following strong earnings from Microsoft.

TD Cowen analyst Krish Sankar maintains KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) with a Hold and raises the price target from $650 to $700.

KLAC

TD Cowen Maintains Hold on KLA, Raises Price Target to $700

Oppenheimer analyst Noah Kaye maintains Carrier Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) with a Outperform and raises the price target from $63 to $64.

CARR

Oppenheimer Maintains Outperform on Carrier Global, Raises Price Target to $64

Oppenheimer analyst Bryan Blair maintains Carlisle Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>) with a Outperform and raises the price target from $412 to $430.

Oppenheimer Maintains Outperform on Carlisle Companies, Raises Price Target to $430

Oppenheimer analyst Ittai Kidron maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Outperform and lowers the price target from $300 to $250.

Oppenheimer Maintains Outperform on Atlassian, Lowers Price Target to $250

TD Cowen analyst Matt Elkott maintains Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) with a Buy and raises the price target from $338 to $340.

TD Cowen Maintains Buy on Caterpillar, Raises Price Target to $340

<a href="https://www.wsj.com/business/media/paramount-considers-removing-ceo-bob-bakish-as-turmoil-over-sale-talks-deepens-a48b0ec5?mod=latest_headlines">https://www.wsj.com/business/media/paramount-considers-removing-ceo-bob-bakish-as-turmoil-over-sale-talks-deepens-a48b0ec5?mod=latest_headlines</a>
&nbsp;

PARA

'Paramount Considers Removing CEO Bob Bakish As Turmoil Over Sale Talks Deepens' - Wall Street Journal

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Nano-cap stocks, or those with tiny market capitalizations, can offer some of the biggest potential returns in the market. With their tiny size, these little-known companies have ample room to deliver outsized gains. Of course, where there&rsquo;s great reward, there&rsquo;s also great risk. No one, not even the shrewdest stock picker, can predict whether a given nano-cap will hit the jackpot or go bust.



The main challenge with assessing nano-caps is their lack of analyst coverage and inconsistent financial reporting. You&rsquo;re often investing based on limited information, and need to take management at its word. That&rsquo;s why these stocks are as risky as they are potentially lucrative.



Still, if you have some &ldquo;fun money&rdquo; set aside, it could pay to target a few nano-caps with quality underlying businesses and strong growth prospects. Success is never guaranteed. But the rewards of investing in these stocks could be life-changing. That is, if you pick the next big winner before it takes off. Let&rsquo;s have a look at three nano-cap stocks to buy!



<h2>Victory Square Technologies (VSQTF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/07/private_equity_1600-300x169.jpg" alt='Gold and silver gears with the words "private equity" written on the gold gears. representing netcapital platform'><div>Source: Pavel3d/ShutterStock.com</div></div>Victory Square Technologies (OTCMKTS:<a href="https://investorplace.com/stock-quotes/vsqtf-stock-quote/">VSQTF</a>) is a Vancouver-based private equity and venture capital firm. The company has built an intriguing portfolio of startups and early-stage companies across some of the most exciting tech sectors today. These sectors span blockchain and digital health to Web 3.0, the creator economy, metaverse, machine learning, and climate tech. What I like is that Victory Square doesn&rsquo;t just provide capital. This company also provides senior leadership and resources to really nurture these young companies and set them up for success.



Now, VSQTF stock has been fairly stagnant over the past couple of years. However, the sectors this company focused on have been absolutely on fire. I suspect that if they can land a few bigger contracts and partnerships, it could be the catalyst that ignites serious growth. <a href="https://victorysquare.com/blog/news/victory-square-technologies-reports-2023-q3-financial-results">Revenue in Q3 2023 was CAD$3.2 million</a> compared to CAD$1.6 million for the same period last year. So, the trend is certainly pointing in the right direction. Moreover, with about CAD$2.4 million in cash, they have some dry powder to keep expanding too.



Victory Square is still a very speculative play. But I believe the upside potential outweighs the risk for investors with a healthy risk appetite.



<h2>InsuraGuest Technologies (ISGIF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/12/insurance-audit-300x169.jpg" alt='a person holds up a scrap of paper that asks "Are you covered?"'><div>Source: Shutterstock</div></div>Next up is a tiny insurance tech company called InsuraGuest Technologies (OTCMKTS:<a href="https://investorplace.com/stock-quotes/isgif-stock-quote/">ISGIF</a>). What caught my attention with this company is their innovative approach to making insurance more customer-centric and hassle-free.



I know insurance isn&rsquo;t the sexiest industry. But InsuraGuest is doing something unique within the space. And at a market cap below $1 million, the stock is trading for pocket change right now. 



Of course, at that valuation, it&rsquo;s a speculative bet, and you have to be prepared to lose it all if things don&rsquo;t pan out. But if they can continue expanding their partnerships and gaining traction with consumers, I could see this one surprising to the upside. Revenue increased nicely to <a href="https://www.google.com/finance/quote/ISGIF:OTCMKTS">$226,162 in Q2 2023</a> from $171,969 a year earlier. Sure, they&rsquo;re still operating at a loss, but this loss narrowed to $162,630 from $183,861 in the same period. As long as they keep moving in the right direction, ISGIF stock might be worth a small position for risk-tolerant investors.



<h2>Online Vacation Center (ONVC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/02/cruise1600-300x169.jpg" alt="a cruise ship in the ocean with the sun going down"><div>Source: Shutterstock.com</div></div>Online Vacation Center (OTCMKTS:<a href="https://investorplace.com/stock-quotes/onvc-stock-quote/">ONVC</a>) can benefit from remote work becoming mainstream and more people migrating to warmer southern states. The Florida-based cruise retailer looks well-positioned to benefit from the pent-up travel demand. They&rsquo;ve been in the cruise business for nearly 50 years, so they have the relationships and expertise to secure exclusive deals.



I believe now is an opportune time to bet on a resurgence before the busy summer cruise season. The stock has already started to wake up, rallying 73% over the past year. But at a still-depressed valuation, I think there could be a lot more upside ahead if Online Vacation Center can entice more travelers to set sail. Revenue surged to <a href="https://www.onlinevacationcenter.com/ir/documents/fy-2022-ovch-financials.pdf">$14.2 million in 2022</a> from just $6.4 million the prior year as cruise demand recovered. So, while it&rsquo;s still a risky nano-cap, I believe the risk/reward is attractive at current levels.



Again, I want to be very clear that these are highly speculative, early-stage companies. Never invest more than you can afford to lose, as the volatility these stocks provide can be extreme, and there&rsquo;s always a chance these businesses don&rsquo;t succeed. But if you have some money set aside for high-risk, high-potential opportunities, the potential gains can be very rewarding.



<a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a>



On Penny Stocks and Low-Volume Stocks:&nbsp;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&nbsp;<a href="http://investorplace.com/" target="_blank">InvestorPlace.com</a>&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&nbsp;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">How to Profit Without Getting Scammed</a>



On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a>
<div>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/3-nano-cap-stocks-that-can-deliver-life-changing-gains-in-one-year/">3 Nano-Cap Stocks That Can Deliver Life-Changing Gains in One Year</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for InsuraGuest Technologies Stock (OTC:ISGIF)

Wednesday, June 15, 2022